NEWLUX 100U
Pharmaceutical-grade Botulinum Toxin Type A with 99.8% Purity | MFDS/KFDA Approved (LS-231)
Advanced Neurotoxin Formulation
NEWLUX 100U utilizes Medytox’s patented Hall Strain fermentation technology, producing uniform 900kDa neurotoxin complexes with ＞99.8% purity. Clinically proven to reduce dynamic wrinkles with 94% efficacy (n=450 RCT) lasting 4-6 months. Complies with WHO-GMP standards and ISO 13485 quality requirements.
Clinical Advantages
Extended Duration
4-6 months efficacy period, 30% longer than average products (2023 clinical data)
Enhanced Safety
0.02% allergy incidence (2022 safety report), animal component-free formulation
Dual Applications
FDA-cleared for cosmetic and medical use (hyperhidrosis, bruxism)
Core Technologies
- APF Purification: 3-step filtration (endotoxin <0.05 EU/mg)
- Vacuum Lyophilization: Maintains 98% potency for 24 months
- pH Optimization: 6.2±0.3 buffer for optimal dispersion
- Stabilization: 0.5mg human serum albumin per vial
Packaging Specifications
- Content: 100U lyophilized powder/vial
- Diluent: 2.5ml sterile saline (0.9% NaCl)
- Storage: 2-8°C protected from light
- Shelf Life: 24 months unopened
Professional Administration Protocol
Reconstitution
Use provided 0.9% saline (2.5ml/vial). Gently mix without vortexing. Use within 4 hours of reconstitution.
Dosing Guidelines
Glabellar: 20-30U (5 points). Crow’s feet: 12-24U/side. Max 200U/session.
Safety Parameters
Avoid superficial frontal injections. Contraindicated in pregnancy and neuromuscular disorders.
Medical Practitioner Notice
Important: Results vary based on injection technique and patient metabolism. Strictly requires:
- Board-certified practitioner administration
- Comprehensive facial anatomy knowledge
- Immediate discontinuation if adverse reactions occur
Manufacturer disclaims liability for off-label use. Report adverse events to MFDS within 24 hours.
Reviews
There are no reviews yet.